David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
CALL
Deutsche Bank
DB
$72.2B
| $9.15M | 0.01% |
480,900
| – | – |
|
1052
Parker-Hannifin
PH
$128B
| $9.15M | 0.01% |
45,850
-187,894
| -80% | -$34.9M |
|
1053
Ligand Pharmaceuticals
LGND
$5.59B
| $9.15M | 0.01% |
107,119
+48,077
| +81% | +$4.17M |
|
1054
PUT
Devon Energy
DVN
$53.1B
| $9.1M | 0.01% |
219,700
-113,800
| -34% | -$4.31M |
|
1055
Urban Outfitters
URBN
$6.51B
| $9.09M | 0.01% |
259,222
+180,770
| +230% | +$5.07M |
|
|
HZN
1056
DELISTED
Horizon Global Corporation
HZN
| $9.08M | 0.01% |
647,793
+89,326
| +16% | +$1.35M |
|
1057
CALL
Valero Energy
VLO
$99.6B
| $9.08M | 0.01% |
98,800
+46,900
| +90% | +$3.87M |
|
|
PRMW
1058
DELISTED
Primo Water Corporation
PRMW
| $9.07M | 0.01% |
544,642
-394,469
| -42% | -$6.33M |
|
1059
Churchill Downs
CHDN
$6.32B
| $9.07M | 0.01% |
233,844
-21,276
| -8% | -$770K |
|
1060
Performance Food Group
PFGC
$16.6B
| $9.07M | 0.01% |
273,983
+213,986
| +357% | +$6.28M |
|
|
ESIO
1061
DELISTED
Electro Scientific Industries
ESIO
| $9.05M | 0.01% |
422,252
-46,248
| -10% | -$928K |
|
1062
TherapeuticsMD
TXMD
$24M
| $9.05M | 0.01% |
29,953
+15,767
| +111% | +$4.39M |
|
1063
PUT
Signet Jewelers
SIG
$3.24B
| $9.02M | 0.01% |
159,500
-6,200
| -4% | -$379K |
|
|
LFC
1064
DELISTED
China Life Insurance Company Ltd.
LFC
| $9.01M | 0.01% |
2,868,000
+1,856,000
| +183% | +$30.2M |
|
1065
Service Corp International
SCI
$11.5B
| $9M | 0.01% |
241,183
+138,605
| +135% | +$4.96M |
|
|
IPXL
1066
DELISTED
Impax Laboratories, Inc.
IPXL
| $9M | 0.01% |
540,413
-317,057
| -37% | -$5.81M |
|
1067
CBIZ
CBZ
$2.96B
| $8.99M | 0.01% |
581,789
+11,423
| +2% | +$180K |
|
1068
Heron Therapeutics
HRTX
$61.3M
| $8.97M | 0.01% |
495,632
+255,457
| +106% | +$4.17M |
|
1069
Coty
COTY
$2.46B
| $8.97M | 0.01% |
450,878
+341,801
| +313% | +$5.83M |
|
1070
Murphy USA
MUSA
$10.4B
| $8.96M | 0.01% |
111,543
-53,347
| -32% | -$4.03M |
|
1071
Restaurant Brands International
QSR
$28.4B
| $8.96M | 0.01% |
145,786
-22,353
| -13% | -$1.43M |
|
|
BWLD
1072
CALL
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $8.96M | 0.01% |
57,300
+33,200
| +138% | +$4.37M |
|
1073
PUT
Simon Property Group
SPG
$71.4B
| $8.95M | 0.01% |
52,100
| – | – |
|
|
SAVE
1074
DELISTED
Spirit Airlines, Inc.
SAVE
| $8.93M | 0.01% |
199,013
+38,450
| +24% | +$1.48M |
|
|
HES
1075
CALL
DELISTED
Hess
HES
| $8.9M | 0.01% |
187,500
+99,300
| +113% | +$4.48M |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.